News Releases News Releases Year None2026202520242023202220212020201920182016 May, 21 2026 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May, 19 2026 TransMedics to Present at the William Blair 46th Annual Growth Stock Conference May, 5 2026 TransMedics Reports First Quarter 2026 Financial Results Apr, 29 2026 TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH Apr, 23 2026 TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting Apr, 21 2026 TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026 Feb, 27 2026 TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results Feb, 24 2026 TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results Feb, 20 2026 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Feb, 17 2026 TransMedics to Present at Upcoming March Investor Conferences Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 13
News Releases Year None2026202520242023202220212020201920182016 May, 21 2026 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May, 19 2026 TransMedics to Present at the William Blair 46th Annual Growth Stock Conference May, 5 2026 TransMedics Reports First Quarter 2026 Financial Results Apr, 29 2026 TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH Apr, 23 2026 TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting Apr, 21 2026 TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026 Feb, 27 2026 TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results Feb, 24 2026 TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results Feb, 20 2026 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Feb, 17 2026 TransMedics to Present at Upcoming March Investor Conferences Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 13
Apr, 29 2026 TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH
Apr, 23 2026 TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting
Feb, 27 2026 TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
